期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

纤溶系统与急性冠状动脉综合征

Fibrinolytic System and Acute Coronary Syndrome
下载PDF
导出
摘要 越来越多的研究证实,纤溶系统活性降低在急性冠状动脉综合征(ACS)的发生、发展中起重要的作用。纤溶系统活性对ACS的诊断、临床治疗及预后预测的评估有重要价值。本文就ACS时纤溶系统活性变化及临床意义的研究进展进行综述。 Increasing evidence suggested that the degraded activity of fibrinolytic system tray play a pivotal role in the initiation and progression of acute coronary syndrome（ACS）.So the activity of fibrinolytic system can provide valuable information in the diagnosis,assessment of clinical therapy and prognostic prediction of ACS. This article reviews progress of ACS about its activity changes of fibrinolytic system and its clinical significance.
作者 马圣庭 姜婕 贾如意
机构地区 泰山医学院济南临床学院济南市心血管病研究所济南市第四人民医院
出处 《医学综述》 2007年第5期396-398,共3页 Medical Recapitulate
关键词 急性冠状动脉综合征 组织型纤溶酶原激活物 纤溶酶原激活物抑制剂-1 纤维蛋白原 组织因子途径抑制剂 血管性假血友病因子 Acute coronary syndrome Tissue-type plasminogen activator Plasminogen activator inhibitor-1 Fibrinogen Tissue factor pathway inhibitor Van willebrand factor
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献15

  • 1陈灏珠.实用内科学[M](第11版)[M].北京:人民卫生出版社,2003.1814.
  • 2Stranss BH,Lau HK,Bowman KA,et al.Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict agiographie coronary restenosis[J].Circulation,1999,100(15):1616-1619.
  • 3Thogersen AM,Jansson JH,Boman K,et al.Hish plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infaretion in both men and women:evidence for the fibrinolytic system as an independent primary risk factor[J].Circulation,1998,98(21):2241-2247.
  • 4Collet JP,Montalescot G,Vicaut E,et al.Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction prediets mortality[J].Circulation,2003,108(4):391-394.
  • 5Carmeliet P,Moons L,Lijnen R,et al.Inhibitory role of plasminogen activator inhibitor-1 in artefial wound healing and neointima formation:a gene targeting and gene transfer study in mice[J].Circulation,1997,96(9):3180-3191.
  • 6Briges AB.Circadian variation of tissue plasminogen activator and its inhibitor,von willebrand factor antigen and prostacyelin stimulating factorin men with ischemie heart disease[J].Br Hcart J,1993,69(2):121-124.
  • 7Devaraj S,Xu DY,Jialal I.C-reactive protein increases plasminogen activator inhibitor-1 expression and activity iu human aortic endothelial cells:implications for the metabolic syndromeand atherothrombosis[J].Circulation,2003,107(3):398-404.
  • 8Bruno G,Gavallo PP,Bargero G,et al.Hyper fibilnogenemia,metabolic syndrome and coronary heart disease in type 2 diabetes:a population based study[J].Diabetologia,2001,17(2):124.
  • 9Acevedo M,Foody JM,Pearce GL,et al.Fibilnogen:associations with cardiovascular events in an outpatient clinic[J].Am Heart J,2002,143(2):277-282.
  • 10Loukas M.Dabrowski M,Wagner T,et al.Fibfinogen and smooth muscle cell detection in athemsclerotic plaques from stable and unstable angina-an immunohistochemical study[J].Med Sci Monit,2002,8(4):144-148.

共引文献27

医学综述
2007年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部